与化疗药物紫杉醇和卡铂联合用于治疗乳腺癌。
Multiscan s.r.o. /ID# 132689, Pardubice, Czechia
Klinik Loewenstein GmbH /ID# 131925, Löwenstein, Germany
Inonu University /ID# 136569, Malatya, Turkey
University of Illinois - Chicago /ID# 127576, Chicago, Illinois, United States
Allegheny General Hospital /ID# 135094, Pittsburgh, Pennsylvania, United States
University of Pittsburgh MC /ID# 125005, Pittsburgh, Pennsylvania, United States
Mercy Health - Perrysburg Hospital, Perrysburg, Ohio, United States
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Katmai Oncology Group, Anchorage, Alaska, United States
Winship Cancer Institute of Emory University /ID# 124061, Atlanta, Georgia, United States
Parkland Health and Hosp Syste /ID# 128518, Dallas, Texas, United States
Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 128385, Dallas, Texas, United States
Site Reference ID/Investigator# 117451, Madrid, Spain
Site Reference ID/Investigator# 117415, San Antonio, Texas, United States
Site Reference ID/Investigator# 117338, Maastricht, Netherlands
Lehigh Valley Health Network /ID# 133372, Allentown, Pennsylvania, United States
Texas Oncology - Medical City Dallas /ID# 126141, Dallas, Texas, United States
UT Southwestern Medical Center /ID# 133849, Dallas, Texas, United States
Cedars-Sinai Medical Center, Los Angeles, California, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States
Walter Reed National Military Medical Center, Bethesda, Maryland, United States
Reading Hospital, Reading, Pennsylvania, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.